全球心臟衰竭检测设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计心臟衰竭检测设备市场将从 2025 年的 152.5 亿美元成长到 2034 年的 263.4 亿美元，2026 年至 2034 年的复合年增长率为 6.26%。

随着全球心血管疾病发生率的上升，全球心臟衰竭检测设备市场正在迅速扩张。人口老化、久坐的生活方式以及高血压和糖尿病盛行率的不断攀升，都是导致心臟衰竭病例增加的原因。早期检测设备有助于监测心臟功能并预防严重併发症。人们对预防性医疗保健和远端监测解决方案的日益重视，正在推动市场成长。

穿戴式心臟监视器、植入式感测器和基于人工智慧的诊断工具等技术进步是主要驱动力。远端医疗平台与心臟监护设备的整合实现了即时数据共用和及时的临床干预。政府推广心血管健康筛检计画的措施进一步促进了这些技术的普及。此外，医疗机构也正在投资先进的诊断设备，以改善病患的治疗效果。

由于预测分析和机器学习演算法在早期风险评估方面的发展，未来前景十分乐观。新兴市场医疗基础设施的扩张将带来额外的需求。小型化和无线监测系统的持续创新将提高患者的舒适度和依从性。随着医疗系统向疾病预防管理转型，心臟衰竭检测市场预计将迎来强劲成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球心臟衰竭检测设备市场：依产品类型划分

• 市场分析、洞察与预测
• 系统（多普勒血流动力学监测仪、植入式血流动力学监测仪（IHM）、植入式肺动脉监测装置、胸内电阻监测仪、通用心臟衰竭监测仪）
• 资料管理软体

第五章 全球心臟衰竭检测设备市场：依技术划分

• 市场分析、洞察与预测
• 有线
• 无线的

第六章：全球心臟衰竭检测设备市场：依最终用户划分

• 市场分析、洞察与预测
• 门诊手术中心
• 诊断影像中心
• 医院

第七章 全球心臟衰竭侦测设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories Inc
  • Boston Scientific Corporation
  • Medtronic Plc
  • General Electric（GE HealthCare）
  • Koninklijke Philips NV
  • Avertix Medical Inc
  • Endotronix Inc
  • Uscom Ltd
  • Biotronik SE & Co. KG
  • IRhythm Technologies Inc

The Heart Failure Detection Devices Market size is expected to reach USD 26.34 Billion in 2034 from USD 15.25 Billion (2025) growing at a CAGR of 6.26% during 2026-2034.

The Global Heart Failure Detection Devices Market is expanding rapidly due to the increasing prevalence of cardiovascular diseases worldwide. Aging populations, sedentary lifestyles, and rising rates of hypertension and diabetes are contributing to higher heart failure cases. Early detection devices help monitor cardiac function and prevent severe complications. Growing awareness about preventive healthcare and remote monitoring solutions is driving market growth.

Technological advancements such as wearable cardiac monitors, implantable sensors, and AI-based diagnostic tools are key drivers. The integration of telehealth platforms with heart monitoring devices enables real-time data sharing and timely clinical intervention. Government initiatives promoting cardiovascular health screening programs are further supporting adoption. Additionally, healthcare providers are investing in advanced diagnostic equipment to improve patient outcomes.

Future prospects appear promising with the development of predictive analytics and machine learning algorithms for early risk assessment. Expanding healthcare infrastructure in emerging economies will create additional demand. Continuous innovation in miniaturized and wireless monitoring systems will enhance patient comfort and compliance. As healthcare systems shift toward proactive disease management, the heart failure detection devices market is expected to witness robust growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Systems (Doppler Hemodynamics Monitors, Implantable Hemodynamic Monitors (IHM), Implantable Pulmonary Artery Monitoring Devices, Intrathoracic Impedance Monitors, General HF Monitors)
• Data Management Software

By Technology

• Wired
• Wireless

By End User

• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Hospitals

COMPANIES PROFILED

• Abbott Laboratories Inc, Boston Scientific Corporation, Medtronic Plc, General Electric GE HealthCare, Koninklijke Philips NV, Avertix Medical Inc, Endotronix Inc, Uscom Ltd, Biotronik SE Co KG, iRhythm Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Systems (Doppler Hemodynamics Monitors, Implantable Hemodynamic Monitors (IHM), Implantable Pulmonary Artery Monitoring Devices, Intrathoracic Impedance Monitors, General HF Monitors) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Data Management Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Wired Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wireless Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEART FAILURE DETECTION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEART FAILURE DETECTION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories Inc
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Medtronic Plc
  • 9.2.4 General Electric (GE HealthCare)
  • 9.2.5 Koninklijke Philips N.V
  • 9.2.6 Avertix Medical Inc
  • 9.2.7 Endotronix Inc
  • 9.2.8 Uscom Ltd
  • 9.2.9 Biotronik SE & Co. KG
  • 9.2.10 IRhythm Technologies Inc